C8922 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC8922
- Long description
- Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study
- Short description
- Tte w or w/o fol w/cont, f/u
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
I3CEchography/ultrasonography - heart- Added
- January 1, 2008
- Last change
- January 1, 2009 – No change
Frequently asked questions
What is HCPCS code C8922?
C8922 is a HCPCS Level II code for transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study.
Does Medicare cover C8922?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C8911 – Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)
- C8912 – Magnetic resonance angiography with contrast, lower extremity
- C8913 – Magnetic resonance angiography without contrast, lower extremity
- C8914 – Magnetic resonance angiography without contrast followed by with contrast, lower extremity
- C8918 – Magnetic resonance angiography with contrast, pelvis
- C8919 – Magnetic resonance angiography without contrast, pelvis
- C8920 – Magnetic resonance angiography without contrast followed by with contrast, pelvis
- C8921 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete
- C8923 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography
- C8924 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study
- C8925 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report
- C8926 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report
- C8927 – Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis
- C8928 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report
- C8929 – Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography
- C8930 – Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.